Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A. P. Kolpaksidi
Observed names:
A Kolpaksidi,
ALEXANDER KOLPAKSIDI,
Alexander P. Kolpaksidi,
I. P. Kolpaksidi,
А. П. Колпаксиди,
Колпаксиди А. П.
show all 6
Institutions:
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
Observed institutions:
Sechenov University,
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
ORCID:
0000-0001-9388-1019
Observed ORCID:
0000-0001-9388-1019
OpenAlex ID:
A5090320500
Antitumor Drugs Based on Indolocarbazol Derivatives
2021
·
I. P. Kolpaksidi
, M. V. Dmitrieva
, et al.
·
Pharmacy & Pharmacology
·
5
PDF
l-lysine α-oxidase encapsulation in red blood cells - Derived extracellular vesicles as biocompatible nanoplatform for cancer therapy
2025
·
Louay Abo Qoura
, Gulalek Babayeva
, et al.
·
Biochemical and Biophysical Research Communications
·
4
Application of Solid Dispersion Technology to Obtain a Model of Injectable Dosage Form of Indolocarbazole Derivative
2022
·
A. P. Kolpaksidi
, M. V. Dmitrieva
, et al.
·
Drug development & registration
·
4
PDF
Quantitative determination of the N-glycoside derivative of substituted indolo[2,3a]carbazole in innovative dosage forms
2022
·
E. V. Ignatieva
, I. V. Yartseva
, et al.
·
Russian Journal of Biotherapy
·
4
PDF
Development of a Technology for Producing a Stable Injectable Dosage Form of a Hydrophobic Indolocarbazole Derivative
2021
·
MARIA DMITRIEVA
, ALEXANDER KOLPAKSIDI
, et al.
·
International Journal of Applied Pharmaceutics
·
4
PDF
Prospects for the creation of a liposomal gemcitabine delivery system
2025
·
G. A. Oborotov
, M. V. Dmitrieva
, et al.
·
Russian Journal of Biotherapy
·
3
PDF
Effect of the composition of combined solid lipid particles with gefitinib and a photosensitizer on their size, stability and cytotoxic activity
2024
·
L. L. Nikolaeva
, E. V. Sanarova
, et al.
·
Biomedical Photonics
·
2
PDF
Application of Technological and Physical-Chemical Approaches to the Development of Injection Forms of an Indolocarbazole Derivative
2024
·
A. V. Lantsova
, E. V. Sanarova
, et al.
·
Pharmaceutical Chemistry Journal
·
1
Comparative characteristics of pharmaceutical substances activators of the STING signaling pathway
2026
·
S. Shceglov
, M. Dmitrieva
, et al.
·
Farmaciya (Pharmacy)
Application of a risk-based approach to determine critical parameters of the process of obtaining a lyophilisate based on a derivative of LCS-1269
2026
·
A. V. Lantsova
, E. V. Sanarova
, et al.
·
Drug development & registration
PDF
Development and Study of the Properties of Polymeric Submicron Particles of Gefitinib with Photoinduced Release
2025
·
L. L. Nikolaeva
, E. V. Sanarova
, et al.
·
Nanobiotechnology Reports
Разработка и изучение свойств полимерных субмикронных частиц гефитиниба с фотоиндуцированным высвобождением
2025
·
Л. Л. Николаева
, Е. В. Санарова
, et al.
·
Российские нанотехнологии
Перспективы создания липосомальной системы доставки гемцитабина
2025
·
Г. А. Оборотов
, М. В. Дмитриева
, et al.
·
Russian Journal of Biotherapy
Применение технологических и физико-химических подходов при разработке инъекционных форм производного индолокарбазола
2024
·
А. В. Ланцова
, Е. В. Санарова
, et al.
·
Химико-фармацевтический журнал
Obtaining a Water-soluble Form of Hydrophobic Indolelocarbazole Derivative Using Solubilizer Complex
2023
·
A. P. Kolpaksidi
, M. V. Dmitrieva
, et al.
·
Drug development & registration
PDF
Show more works
View as search
Works count:
16
Citation count:
27
H-index:
4
I10-index:
Year
Topic
Type